HuMAB companies Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : HuMAB companies

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (423)	10/2/2002 1:17:22 PM
From: nigel bates	Read Replies (1) of 1022

With ABGX/CRGN vs CAT/HGSI, the resources (and targets) available to each partnership have got to be somewhere about equal. If there is anything to the hype, the next six months or so should be interesting; we'll see. Nice aside on MEDX - a fairly longstanding blurb from their website - We believe that a distinct advantage of Medarex's fully human antibodies is their potential for accelerated development. By combining our technology for creating fully human antibodies with our in-house development and clinical supply manufacturing expertise, we have been able to progress from immunization to IND filing in less than 12 months through our T-12 Development Program.... Seems to have been replaced by this - Using fully human monoclonal antibodies, we believe it is possible to reduce the time and cost of drug development. It has historically taken new pharmaceutical products nearly six years of preclinical development before human clinical trials are initiated. Using fully human monoclonal antibody technology, we believe it is possible to reduce that time to less than two years...

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next